Kura Oncology
(KURA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 53,883 | 0 | 0 | 0 | 0 |
| Gross Profit | 53,883 | N/A | N/A | N/A | N/A |
| Operating Expenses | 247,078 | 165,804 | 139,865 | 131,258 | 91,899 |
| Operating Income | -193,195 | -165,804 | -139,865 | -131,258 | -91,899 |
| Interest Expense | 1,619 | 1,549 | 229 | 414 | 578 |
| Other Income | 22,849 | 14,722 | 4,254 | 1,206 | 2,852 |
| Pre-tax Income | -171,965 | -152,631 | -135,840 | -130,466 | -89,625 |
| Income Tax | 2,018 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -173,983 | -152,631 | -135,840 | -130,466 | -89,625 |
| Net Income | $-173,983 | $-152,631 | $-135,840 | $-130,466 | $-89,625 |
| EPS Basic Total Ops | -2.02 | -2.08 | -2.03 | -1.97 | -1.69 |
| EPS Basic Continuous Ops | -2.02 | -2.08 | -2.03 | -1.97 | -1.69 |
| EPS Diluted Total Ops | -2.02 | -2.08 | -2.03 | -1.97 | -1.69 |
| EPS Diluted Continuous Ops | -2.02 | -2.08 | -2.03 | -1.97 | -1.69 |
| EPS Diluted Before Non-Recurring Items | -2.02 | -2.08 | -2.03 | -1.97 | -1.69 |
| EBITDA(a) | $-205,488 | $-174,375 | $-137,496 | $-126,309 | $-91,295 |